Support of Colonization Resistance of the Gut Microbiota With the Synbiotic Food Supplement Nagasin®

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The aim of this randomized, controlled, double-blind, parallel, multicentric trial is to investigate wether the synbiotic food supplement Nagasin® can support the colonization resistance of the gut microbiota after disturbance by antimicrobial treatment. The main question is whether Nagasin® can prevent any increase in abundance of C.difficile within the first four weeks after antimicrobial treatment for a C. difficile infection. Participants will receive Nagasin® or the comparator as a food supplement during the first four weeks after antimicrobial treatment for a C. difficile episode.
Epistemonikos ID: a5cb42baee083cc0bb01eaa3c4e9e0c2e7617104
First added on: Feb 19, 2024